Literature DB >> 30462539

MicroRNA-146a-5p enhances radiosensitivity in hepatocellular carcinoma through replication protein A3-induced activation of the DNA repair pathway.

Jing Luo1, Zhong-Zhou Si1, Ting Li1, Jie-Qun Li1, Zhong-Qiang Zhang1, Guang-Shun Chen1, Hai-Zhi Qi1, Hong-Liang Yao2.   

Abstract

Hepatocellular carcinoma (HCC) is known for its high mortality rate worldwide. Based on intensive studies, microRNA (miRNA) expression functions in tumor suppression. Therefore, we aimed to evaluate the contribution of miR-146a-5p to radiosensitivity in HCC through the activation of the DNA damage repair pathway by binding to replication protein A3 (RPA3). First, the limma package of R was performed to differentially analyze HCC expression chip, and regulative miRNA of RPA3 was predicted. Expression of miR-146a-5p, RPA3, and DNA damage repair pathway-related factors in tissues and cells was determined. The effects of radiotherapy on the expression of miR-146a-5p and RPA3 as well as on cell radiosensitivity, proliferation, cell cycle, and apoptosis were also assessed. The results showed that there exists a close correlation between miR-146a and the radiotherapy effect on HCC progression through regulation of RPA3 and the DNA repair pathway. The positive rate of ATM, pCHK2, and Rad51 in HCC tissues was higher when compared with that of the paracancerous tissues. SMMC-7721 and HepG2 cell proliferation were significantly inhibited following 8 Gy 6Mv dose. MiR-146a-5p restrained the expression of RPA3 and promoted the expression of relative genes associated with the DNA repair pathway. In addition, miR-146a-5p overexpression suppresses cell proliferation and enhances radiosensitivity and cell apoptosis in HCC cells. In conclusion, the present study revealed that miR-146a-5p could lead to the restriction of proliferation and the promotion of radiosensitivity and apoptosis in HCC cells through activation of DNA repair pathway and inhibition of RPA3.

Entities:  

Keywords:  DNA repair pathway; hepatocellular carcinoma cells; microRNA-146a-5p; radiosensitivity; replication protein A3

Mesh:

Substances:

Year:  2018        PMID: 30462539     DOI: 10.1152/ajpcell.00189.2018

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  12 in total

Review 1.  Noncoding RNA-mediated macrophage and cancer cell crosstalk in hepatocellular carcinoma.

Authors:  Zhixia Zhou; Zhan Wang; Jie Gao; Zhijuan Lin; Yin Wang; Peipei Shan; Mengkun Li; Tingting Zhou; Peifeng Li
Journal:  Mol Ther Oncolytics       Date:  2022-03-16       Impact factor: 6.311

2.  Long noncoding RNA MALAT1 inhibits the apoptosis and autophagy of hepatocellular carcinoma cell by targeting the microRNA-146a/PI3K/Akt/mTOR axis.

Authors:  Ningfu Peng; Jingrong He; Jindu Li; Hao Huang; Weiqiao Huang; Yingyang Liao; Shaoliang Zhu
Journal:  Cancer Cell Int       Date:  2020-05-13       Impact factor: 5.722

3.  The HBx-CTTN interaction promotes cell proliferation and migration of hepatocellular carcinoma via CREB1.

Authors:  Yajun Li; Yongming Fu; Xingwang Hu; Lunquan Sun; Daolin Tang; Ning Li; Fang Peng; Xue-Gong Fan
Journal:  Cell Death Dis       Date:  2019-05-28       Impact factor: 8.469

4.  Reduced expression of microRNA-139-5p in hepatocellular carcinoma results in a poor outcome: An exploration the roles of microRNA-139-5p in tumorigenesis, advancement and prognosis at the molecular biological level using an integrated meta-analysis and bioinformatic investigation.

Authors:  Hui Qin; Dong-Yue Wen; Qiao Que; Chuan-Yang Zhou; Xiao-Dong Wang; Yu-Ting Peng; Yun He; Hong Yang; Bo-Ming Liao
Journal:  Oncol Lett       Date:  2019-11-01       Impact factor: 2.967

Review 5.  Application of Radiosensitizers in Cancer Radiotherapy.

Authors:  Liuyun Gong; Yujie Zhang; Chengcheng Liu; Mingzhen Zhang; Suxia Han
Journal:  Int J Nanomedicine       Date:  2021-02-12

6.  LncRNA KCNQ1OT1 inhibits the radiosensitivity and promotes the tumorigenesis of hepatocellular carcinoma via the miR-146a-5p/ACER3 axis.

Authors:  Ganghua Yang; Lijing Zhou; Qinhong Xu; Fandi Meng; Yong Wan; Xiankui Meng; Lin Wang; Lei Zhang
Journal:  Cell Cycle       Date:  2020-09-16       Impact factor: 4.534

7.  High-Throughput MicroRNA Profiling of Vitreoretinal Lymphoma: Vitreous and Serum MicroRNA Profiles Distinct from Uveitis.

Authors:  Teruumi Minezaki; Yoshihiko Usui; Masaki Asakage; Masakatsu Takanashi; Hiroyuki Shimizu; Naoya Nezu; Akitomo Narimatsu; Kinya Tsubota; Kazuhiko Umazume; Naoyuki Yamakawa; Masahiko Kuroda; Hiroshi Goto
Journal:  J Clin Med       Date:  2020-06-12       Impact factor: 4.241

Review 8.  miRNA-based biomarkers, therapies, and resistance in Cancer.

Authors:  Boxue He; Zhenyu Zhao; Qidong Cai; Yuqian Zhang; Pengfei Zhang; Shuai Shi; Hui Xie; Xiong Peng; Wei Yin; Yongguang Tao; Xiang Wang
Journal:  Int J Biol Sci       Date:  2020-07-19       Impact factor: 6.580

Review 9.  Radiosensitization of Hepatocellular Carcinoma through Targeting Radio-Associated MicroRNA.

Authors:  Cheng-Heng Wu; Cheng-Yi Chen; Chau-Ting Yeh; Kwang-Huei Lin
Journal:  Int J Mol Sci       Date:  2020-03-09       Impact factor: 5.923

10.  Preoperative serum circulating microRNAs as potential biomarkers for chronic postoperative pain after total knee replacement.

Authors:  Rocco Giordano; Kristian Kjær Petersen; Hjalte Holm Andersen; Jacek Lichota; Massimiliano Valeriani; Ole Simonsen; Lars Arendt-Nielsen
Journal:  Mol Pain       Date:  2020 Jan-Dec       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.